Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 95029043 | 9502904 | 3 | F | 20120709 | 20160816 | 20130906 | 20160822 | PER | PHHY2013US097208 | NOVARTIS | 34.98 | YR | F | Y | 0.00000 | 20160822 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 95029043 | 9502904 | 1 | PS | GILENYA | FINGOLIMOD HYDROCHLORIDE | 1 | Oral | UNK, QD | 22527 | CAPSULE | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 95029043 | 9502904 | 1 | Multiple sclerosis |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 95029043 | 9502904 | Alanine aminotransferase increased | |
| 95029043 | 9502904 | Blood urea decreased | |
| 95029043 | 9502904 | Eye pain | |
| 95029043 | 9502904 | Haematocrit decreased | |
| 95029043 | 9502904 | Haemoglobin decreased | |
| 95029043 | 9502904 | Lymphocyte count decreased | |
| 95029043 | 9502904 | Psoriasis | |
| 95029043 | 9502904 | Weight increased | |
| 95029043 | 9502904 | White blood cell count decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |